API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
54
PharmaCompass offers a list of Fosinopril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosinopril manufacturer or Fosinopril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosinopril manufacturer or Fosinopril supplier.
PharmaCompass also assists you with knowing the Fosinopril API Price utilized in the formulation of products. Fosinopril API Price is not always fixed or binding as the Fosinopril Price is obtained through a variety of data sources. The Fosinopril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fosinopril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosinopril, including repackagers and relabelers. The FDA regulates Fosinopril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosinopril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosinopril manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosinopril supplier is an individual or a company that provides Fosinopril active pharmaceutical ingredient (API) or Fosinopril finished formulations upon request. The Fosinopril suppliers may include Fosinopril API manufacturers, exporters, distributors and traders.
click here to find a list of Fosinopril suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fosinopril DMF (Drug Master File) is a document detailing the whole manufacturing process of Fosinopril active pharmaceutical ingredient (API) in detail. Different forms of Fosinopril DMFs exist exist since differing nations have different regulations, such as Fosinopril USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fosinopril DMF submitted to regulatory agencies in the US is known as a USDMF. Fosinopril USDMF includes data on Fosinopril's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fosinopril USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fosinopril suppliers with USDMF on PharmaCompass.
A Fosinopril CEP of the European Pharmacopoeia monograph is often referred to as a Fosinopril Certificate of Suitability (COS). The purpose of a Fosinopril CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fosinopril EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fosinopril to their clients by showing that a Fosinopril CEP has been issued for it. The manufacturer submits a Fosinopril CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fosinopril CEP holder for the record. Additionally, the data presented in the Fosinopril CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fosinopril DMF.
A Fosinopril CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fosinopril CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fosinopril suppliers with CEP (COS) on PharmaCompass.
A Fosinopril written confirmation (Fosinopril WC) is an official document issued by a regulatory agency to a Fosinopril manufacturer, verifying that the manufacturing facility of a Fosinopril active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fosinopril APIs or Fosinopril finished pharmaceutical products to another nation, regulatory agencies frequently require a Fosinopril WC (written confirmation) as part of the regulatory process.
click here to find a list of Fosinopril suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosinopril as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosinopril API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosinopril as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosinopril and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosinopril NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosinopril suppliers with NDC on PharmaCompass.
Fosinopril Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosinopril GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosinopril GMP manufacturer or Fosinopril GMP API supplier for your needs.
A Fosinopril CoA (Certificate of Analysis) is a formal document that attests to Fosinopril's compliance with Fosinopril specifications and serves as a tool for batch-level quality control.
Fosinopril CoA mostly includes findings from lab analyses of a specific batch. For each Fosinopril CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosinopril may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosinopril EP), Fosinopril JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosinopril USP).